Adamant Biomedical Investments’s Humana HUM Stock Holding History

Adamant Biomedical Investments’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$4.31M	Sell	30,000 -5,000	-14%	-$683K	1.03%	36
2014 Q3	$4.56M	Buy	+35,000	New	+$4.45M	1.14%	33

Other funds holding HUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ETC

Evercore Trust Company New York $34.6B AUM 25.41% 1-Year Est. Return

Adamant Biomedical Investments's HUM Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Humana (HUM) stake by 14% in Q4 2014, selling an estimated $683K and leaving 30,000 shares worth $4.31M. The position accounts for 1.03% of the portfolio, ranked #36.

Adamant Biomedical Investments first reported a position in HUM in Q3 2014 and has held it in 2 quarters since. The position peaked at $4.56M in Q3 2014. 542 funds tracked by Wall St. Rank hold HUM as of Q4 2014.

Adamant Biomedical Investments held 30,000 shares of Humana worth $4.31M as of Q4 2014.
Adamant Biomedical Investments sold 5,000 Humana shares in Q4 2014, an estimated $683K.
Humana made up 1.03% of Adamant Biomedical Investments's portfolio in Q4 2014, its #36 holding.
Adamant Biomedical Investments first reported a position in Humana in Q3 2014 and has held it in 2 quarters since.
Adamant Biomedical Investments's Humana position peaked at $4.56M in Q3 2014.
542 funds tracked by Wall St. Rank held Humana as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.